From: Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation
Variables | All (n = 349) | Non-TR group (n = 318) | TR group (n = 31) | p |
---|---|---|---|---|
Operative procedures | ||||
Bicaval anastomosis | 243 (69.6%) | 221 (69.5%) | 22 (71.0%) | 0.97 |
Total anastomosis | 106 (30.4%) | 97 (30.5%) | 9 (29.0%) | |
Ischemic time (min) | 238.2 ± 60.5 | 237.4 ± 60.7 | 246.0 ± 60.3 | 0.47 |
Cardiopulmonary bypass time (min) | 202.1 ± 60.7 | 202.4 ± 61.5 | 197.4 ± 54.3 | 0.67 |
Cross clamp time (min) | 150.8 ± 38.7 | 150.8 ± 39.1 | 150.1 ± 36.9 | 0.92 |
Implant time (min) | 89.7 ± 19.4 | 89.9 ± 19.2 | 87.3 ± 22.2 | 0.49 |
Reperfusion time (min) | 33.3 ± 18.5 | 33.4 ± 18.3 | 32.4 ± 21.1 | 0.78 |
Early outcomes | ||||
In hospital mortality | 11 (3.2%) | 11 (3.5%) | 0 (0%) | 0.15 |
ECMO | 27 (7.7%) | 23 (7.2%) | 4 (12.9%) | 0.30 |
Hemodialysis | 27 (7.7%) | 20 (6.3%) | 7 (22.6%) | < 0.01 |
Re-exploration | 33 (9.5%) | 29 (9.1%) | 4 (12.9%) | 0.51 |
Stroke | 14 (4.0%) | 13 (4.1%) | 1 (3.2%) | 0.81 |
CVP (mmHg) | 8.3 ± 4.5 | 8.0 ± 4.4 | 10.8 ± 5.5 | < 0.01 |
Mean PAP (mmHg) | 24.6 ± 7.2 | 24.3 ± 7.2 | 27.6 ± 6.6 | 0.02 |
PCWP (mmHg) | 15.7 ± 5.7 | 15.4 ± 5.6 | 18.5 ± 5.6 | < 0.01 |
PAPi | 3.1 ± 2.5 | 3.17 ± 2.6 | 2.25 ± 1.1 | 0.06 |
CVP/PAWP | 0.52 ± 0.2 | 0.51 ± 0.2 | 0.60 ± 0.2 | < 0.01 |
CI (L/min/m2) | 3.1 ± 0.7 | 3.1 ± 0.7 | 3.0 ± 0.6 | 0.40 |